Monoterpenoid Glycosides from the Leaves of Ligustrum robustum and Their Bioactivities

被引:9
作者
Lu, Shi-Hui [1 ]
Huang, Jing [2 ]
Zuo, Hao-Jiang [3 ]
Zhou, Zhong-Bo [1 ]
Yang, Cai-Yan [1 ]
Huang, Zu-Liang [1 ]
机构
[1] Youjiang Med Univ Nationalities, Coll Pharm, Baise 533000, Peoples R China
[2] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting, Minist Educ, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Sch Publ Hlth, Dept Lab Sci Publ Hlth, Chengdu 610041, Peoples R China
来源
MOLECULES | 2022年 / 27卷 / 12期
关键词
Ligustrum robustum; monoterpenoid glycoside; FAS; alpha-glucosidase; antioxidant; anti-obesity; hypoglycemic; FATTY-ACID SYNTHASE; EXTRACT; BLUME;
D O I
10.3390/molecules27123709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The leaves of Ligustrum robustum have been applied as Ku-Ding-Cha, a functional tea to clear heat, remove toxins, and treat obesity and diabetes, in Southwest China. The phytochemical research on the leaves of L. robustum led to the isolation and identification of eight new monoterpenoid glycosides (1-8) and three known monoterpenoid glycosides (9-11). Compounds 1-11 were tested for the inhibitory activities on fatty acid synthase (FAS), alpha-glucosidase, alpha-amylase, and the antioxidant effects. Compound 2 showed stronger FAS inhibitory activity (IC50: 2.36 +/- 0.10 mu M) than the positive control orlistat (IC50: 4.46 +/- 0.13 mu M), while compounds 1, 2, 5 and 11 displayed more potent ABTS radical scavenging activity (IC50: 6.91 +/- 0.10 similar to 9.41 +/- 0.22 mu M) than the positive control L-(+)-ascorbic acid (IC50: 10.06 +/- 0.19 mu M). This study provided a theoretical basis for the leaves of L. robustum as a functional tea to treat obesity.
引用
收藏
页数:14
相关论文
共 21 条
  • [1] Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target
    Buckley, Douglas
    Duke, Gregory
    Heuer, Timothy S.
    O'Farrell, Marie
    Wagman, Allan S.
    McCulloch, William
    Kemble, George
    [J]. PHARMACOLOGY & THERAPEUTICS, 2017, 177 : 23 - 31
  • [2] Inhibitory effects of tannic acid on fatty acid synthase and 3T3-L1 preadipocyte
    Fan, Huijin
    Wu, Dan
    Tian, Weixi
    Ma, Xiaofeng
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2013, 1831 (07): : 1260 - 1266
  • [3] Antioxidative glycosides from the leaves of Ligustrum robustum
    He, ZD
    Lau, KM
    But, PPH
    Jiang, RW
    Dong, H
    Ma, SC
    Fung, KP
    Ye, WC
    Sun, HD
    [J]. JOURNAL OF NATURAL PRODUCTS, 2003, 66 (06): : 851 - 854
  • [4] MONOTERPENOID AND PHENYLETHANOID GLYCOSIDES FROM LIGUSTRUM PEDUNCULARE
    HE, ZD
    UEDA, S
    AKAJI, M
    FUJITA, T
    INOUE, K
    YANG, CR
    [J]. PHYTOCHEMISTRY, 1994, 36 (03) : 709 - 716
  • [5] Scopoletin inhibits α-glucosidase in vitro and alleviates postprandial hyperglycemia in mice with diabetes
    Jang, June Hyuk
    Park, Jae Eun
    Han, Ji Sook
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 834 : 152 - 156
  • [6] Anti-oxidative, anti-inflammatory and hepato-protective effects of Ligustrum robustum
    Lau, KM
    He, ZD
    Dong, H
    Fung, KP
    But, PPH
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2002, 83 (1-2) : 63 - 71
  • [7] Two new phenethanol glycosides from Ligustrum robustum
    Li, Li
    Peng, Yong
    Liu, Yong
    Xu, Li Jia
    Guo, Na
    Shi, Ren Bing
    Xiao, Pei Gen
    [J]. CHINESE CHEMICAL LETTERS, 2011, 22 (03) : 326 - 329
  • [8] Chemical constituents from Ligustrum robustum Bl
    Li, Li
    Peng, Yong
    Xu, Li-Jia
    Wu-Lan, Ta-Na
    Shi, Ren-Bing
    Xiao, Pei-Gen
    [J]. BIOCHEMICAL SYSTEMATICS AND ECOLOGY, 2010, 38 (03) : 398 - 401
  • [9] Two new glycosides from the leaves of Ligustrum robustum and their antioxidant activities and inhibitory effects on α-glucosidase and α-amylase
    Lu, S. -H.
    Zuo, H. -J.
    Shi, J. -X.
    Li, C. -R.
    Li, Y. -H.
    Wang, X.
    Li, L. -R.
    Huang, J.
    [J]. SOUTH AFRICAN JOURNAL OF BOTANY, 2019, 125 : 521 - 526
  • [10] Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy
    Lu, Tianbao
    Schubert, Carsten
    Cummings, Maxwell D.
    Bignan, Gilles
    Connolly, Peter J.
    Smans, Karine
    Ludovici, Donald
    Parker, Michael H.
    Meyer, Christophe
    Rocaboy, Christian
    Alexander, Richard
    Grasberger, Bruce
    De Breucker, Sabine
    Esser, Norbert
    Fraiponts, Erwin
    Gilissen, Ron
    Janssens, Boudewijn
    Peeters, Danielle
    Van Nuffel, Luc
    Vermeulen, Peter
    Bischoff, James
    Meerpoel, Lieven
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) : 2159 - 2164